| # | Drug | Count |
|---|---|---|
| 0 | CINACALCET | 25 |
| 1 | CINACALCET HYDROCHLORIDE | 19 |
| 2 | MYCOPHENOLATE MOFETIL | 12 |
| 3 | MYCOPHENOLATE MOFETIL HYDROCHLORIDE | 12 |
| 4 | TACROLIMUS | 12 |
| 5 | BUROSUMAB | 11 |
| 6 | ECULIZUMAB | 10 |
| 7 | TACROLIMUS EXTENDED-RELEASE CAPSULES | 10 |
| 8 | TACROLIMUS OINTMENT 0.1% | 10 |
| 9 | CALCITRIOL | 9 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | POTASSIUM PHOSPHATE, MONOBASIC AND SODIUM PHOSPHATE, MONOBASIC, ANHYDROUS | 1 | 0.0055 |
| 1 | SODIUM THIOSULFATE | 2 | 0.0036 |
| 2 | DIBASIC SODIUM PHOSPHATE, MONOBASIC POTASSIUM PHOSPHATE AND MONOBASIC SODIUM PHOSPHATE | 1 | 0.0030 |
| 3 | PENICILLIN V POTASSIUM | 5 | 0.0019 |
| 4 | SEVELAMER HYDROCHLORIDE | 1 | 0.0017 |
| 5 | BUROSUMAB | 11 | 0.0017 |
| 6 | ETELCALCETIDE | 3 | 0.0010 |
| 7 | CALCITRIOL CAPSULES 0.25 MCG | 9 | 0.0004 |
| 8 | PARICALCITOL | 6 | 0.0004 |
| 9 | CINACALCET HYDROCHLORIDE | 19 | 0.0004 |
| # | Drug class | Count |
|---|---|---|
| 0 | Complement Inhibitor [EPC] | 10 |
| 1 | Provitamin D2 Compound [EPC] | 9 |
| 2 | Vitamin D3 Analog [EPC] | 9 |
| 3 | Corticosteroid [EPC] | 8 |
| 4 | Purine Antimetabolite [EPC] | 8 |
| 5 | Dihydropyridine Calcium Channel Blocker [EPC] | 7 |
| 6 | Vitamin D Analog [EPC] | 6 |
| 7 | Vitamin D2 Analog [EPC] | 6 |
| 8 | Nonsteroidal Anti-inflammatory Drug [EPC] | 4 |
| 9 | Benzodiazepine [EPC] | 3 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Vitamin D2 Analog [EPC] | 6 | 0.0008 |
| 1 | Vitamin D3 Analog [EPC] | 9 | 0.0004 |
| 2 | Vitamin D Analog [EPC] | 6 | 0.0003 |
| 3 | Provitamin D2 Compound [EPC] | 9 | 0.0003 |
| 4 | Complement Inhibitor [EPC] | 10 | 0.0002 |
| 5 | Tetracycline-class Antibacterial [EPC] | 1 | 0.0001 |
| 6 | Vitamin K [EPC] | 1 | 0.0001 |
| 7 | Cytomegalovirus Nucleoside Analog DNA Polymerase Inhibitor [EPC] | 2 | 0.0001 |
| 8 | Purine Antimetabolite [EPC] | 8 | 0.0001 |
| 9 | Prostaglandin E1 Analog [EPC] | 1 | 0.0001 |